EIGER BIOPHARMACEUTICALS INC (EIGR)
US28249U2042 - Common Stock
ChartMill assigns a Buy % Consensus number of 88% to EIGR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 91.8. This target is 5221.74% above the current price.
EIGR was analyzed by 8 analysts. The buy percentage consensus is at 88. So analysts seem to be very confident about EIGR.
In the previous month the buy percentage consensus was at a similar level.
EIGR was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-08-29 | Citigroup | Maintains | Buy -> Buy |
| 2023-06-30 | Baird | Maintains | Outperform -> Outperform |
| 2022-09-07 | BTIG | Maintains | Buy |
| 2021-08-09 | Citigroup | Maintains | Buy |